➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Medtronic
McKesson
AstraZeneca
Harvard Business School

Last Updated: May 31, 2020

DrugPatentWatch Database Preview

Sun Pharma Global Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for SUN PHARMA GLOBAL, and when can generic versions of SUN PHARMA GLOBAL drugs launch?

SUN PHARMA GLOBAL has eighteen approved drugs.

There are fifteen US patents protecting SUN PHARMA GLOBAL drugs. There are five tentative approvals on SUN PHARMA GLOBAL drugs.

There are one hundred and eighty patent family members on SUN PHARMA GLOBAL drugs in fifty-one countries and sixty-six supplementary protection certificates in fifteen countries.

Summary for Sun Pharma Global
International Patents:180
US Patents:15
Tradenames:18
Ingredients:17
NDAs:18
Patent Litigation for Sun Pharma Global: See patent lawsuits for Sun Pharma Global

Drugs and US Patents for Sun Pharma Global

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharma Global ESOMEPRAZOLE SODIUM esomeprazole sodium INJECTABLE;INTRAVENOUS 200882-001 Mar 18, 2013 DISCN No No   Start Trial   Start Trial
Sun Pharma Global DRIZALMA SPRINKLE duloxetine hydrochloride CAPSULE, DELAYED RELEASE;ORAL 212516-003 Jul 19, 2019 RX Yes No 9,839,626   Start Trial Y   Start Trial
Sun Pharma Global CEQUA cyclosporine SOLUTION;OPHTHALMIC 210913-001 Aug 14, 2018 RX Yes Yes 8,980,839   Start Trial Y   Start Trial
Sun Pharma Global DOCEFREZ docetaxel INJECTABLE;INJECTION 022534-002 May 3, 2011 DISCN Yes No   Start Trial   Start Trial
Sun Pharma Global ORTIKOS budesonide CAPSULE, EXTENDED RELEASE;ORAL 211929-001 Jun 13, 2019 RX Yes No 9,707,182   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for SUN PHARMA GLOBAL drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 125 mg ➤ Subscribe 2018-07-23

Supplementary Protection Certificates for Sun Pharma Global Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0720599 300688 Netherlands   Start Trial PRODUCT NAME: EZETIMIBE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, EN ROSUVASTATINE; NATIONAL REGISTRATION NO/DATE: RVG114002-004 20140811; FIRST REGISTRATION: NO 13-9663 - 9665 20140724
1667986 92172 Luxembourg   Start Trial PRODUCT NAME: SOLVAT ACETONIQUE DU CABAZITAXEL, OU DESIGNE SOLVAT ACETONIQUE DU DIMETHOXY DOCETAXEL OU SOLVAT ACETONIQUE DU (2R,3S)-3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DE 4-ACETOXY-2A-BENZOYLOXY-5BETA,20-EPOXY-1-HYDROXY-7BETA,10A-DIMETHOXY-9-OXO-TAX-11-ENE-13A-YLE(ACETONATE DU CABAZITAXEL)
1586316 C 2011 004 Romania   Start Trial PRODUCT NAME: BROMFENAC, SARURILE SI HIDRATII SAI ACCEPTABILI FARMACEUTICACID 2-[2-AMINO-3-(4-BROMOBENZOIL)FENILACETIC; NATIONAL AUTHORISATION NUMBER: RO EU/1/11/692/001; DATE OF NATIONAL AUTHORISATION: 20110518; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EMEA EU/1/11/692/001; DATE OF FIRST AUTHORISATION IN EEA: 20110518
0364417 SPC/GB97/014 United Kingdom   Start Trial PRODUCT NAME: LATANOPROST (I.E. 13,14-DIHYDRO-17-PHENYL-18,19,20-TRINOR-PGF-ALPHA-ISOPROPYLESTER); NAT. REGISTRATION NO/DATE: 00032/0220 19961216; FIRST REGISTRATION: SE 12716 19960718; SPC EXTENSION AUTHORISATION: PL00057/1057-008 20101216
0984957 SPC/GB11/013 United Kingdom   Start Trial PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Mallinckrodt
Baxter
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.